Home › Ischemia › NCT05868902

A Registry of Cardiac PET and CardioFlux Magnetocardiography in Patients With Suspected Coronary Ischemia.

Who can join

Ages 40 and older · All sexes

Inclusion Criteria:

* Willing to provide informed consent
* Male or female, aged 40 and up (inclusive) at the time of enrollment
* Clinical suspicion of myocardial ischemia that clinician desired cardiac PET
* Completed cardiac PET within 2 weeks prior to study enrollment

Exclusion Criteria:

* Patients unable to fit into CardioFlux device.
* Patients unable to lie supine for 5 minutes.
* Patients with implanted ferromagnetic objects above the costal margin of the rib cage (implanted pacemakers, cardioverter/defibrillators, infusion pumps, and/or neuro stimulators). NOTE: Sternotomy wires stents are acceptable
* Ongoing atrial fibrillation or atrial flutter
* Life expectancy \<1 yrs. due to non-cardiovascular comorbidity

About the study

A multicenter observational data development registry collecting diagnostic measures via standard of care (SOC) cardiac PET in order gain a better understanding of how CardioFlux MCG may be used in the detection of coronary ischemia.

What is being tested

• CardioFlux Magnetocardiography (device)

Sponsor: Genetesis Inc. · Participants: 300 · Started: Aug 28, 2023

Contact the study team

• Zoe E Swann, PhD · Phone: 4802868695

Official record on ClinicalTrials.gov — NCT05868902

Locations in the U.S.

Conditions

• Ischemia

From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.